AzTrials
AzTrials

Visual FatigueNCT02407015

The Effect of 3D Autostereoscopic Video-game Play on the Visual Fatigue in Children

A study testing Nintendo 3DS gameplay in people with Visual Fatigue, run by University of Sheffield at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the specific effect that 3D game play has on the control of the eyes horizontal movements. It will examine the youngest group of consumers this technology is marketed to, 7 to 11-year-olds and no children under 7 years of age will be recruited to this study as per Nintendo's hardware… Read more about this study

Who is it for?
Ages 7 to 11 yearsHealthy volunteers can take part
Conditions the study is for
Visual Fatigue
What is being tested?
Nintendo 3DS gameplay
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited Kingdom
Study dates
Dec 2014to May 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 11 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Male and female 7 to 11-year-olds with no prior history of binocular vision / ocular motility dysfunction.

Who cannot join

  • Corrected visual acuity of less than 0.000 tested with SLT at 3m.
  • Interocular visual acuity difference of 0.100 (tested with SLT) or greater, which could indicate the presence of Amblyopia.
  • The presence of any manifest deviation (Tropia).
  • Presence of any ocular motility dysfunction, which affects primary position.
  • Reduced binocular convergence of 10 centimetres or less.
  • Stereoacuity of less than 170" (this may indicate the presence of a microtropia or other undiagnosed pathology).
  • Any prior or existing medical history of epilepsy or seizures.
  • Any prior or existing medical history of repetitive strain injury.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Cambridge University Hospitals NHS trust

    Cambridge, Cambridgeshire, CB20QQ

Other trials in United Kingdom

About this study

Official title: A Randomised Control Trial to Evaluate the Effect of 3D Autostereoscopic Video-game Play on the Total Horizontal Fusional Vergence Amplitudes of 7 to 11 Year Old Children

This study aims to examine the specific effect that 3D game play has on the control of the eyes horizontal movements. It will examine the youngest group of consumers this technology is marketed to, 7 to 11-year-olds and no children under 7 years of age will be recruited to this study as per Nintendo's hardware guidelines, which recommends that children under 7 years of age not play in 3D mode. It will examine the effect of playing in 3D for 30 minutes on horizontal fusional amplitudes compared with a control group playing in 2D for 30 minutes.

Read the detailed description

This study will be a prospective blind randomised control trial. The participants will be randomised into one study group, with participants playing a game in 3D; and a control group, with participants playing the same game in 2D. The study is blind due to the use of an independent assessor, reducing testing bias by ensuring that the tester does not know the randomisation results. The known dependant variables are the total horizontal fusional amplitudes at 1/3m and 6m and the independent variable is the use of 2D or 3D game play.

Conditions
Visual Fatigue
Being tested
Nintendo 3DS gameplay
Medical subject headings
Asthenopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nintendo 3DS gameplayOther

Study groups in NCT02407015
Study groupRoleWhat they receive
3D gameplayActive comparatorParticipants will play a game for 30 minutes on the Nintendo 3DS in 3D.
Receives: Other: Nintendo 3DS gameplay
2D gameplayActive comparatorParticipants will play a game for 30 minutes on the nintendo 3DS in 2D.
Receives: Other: Nintendo 3DS gameplay

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in horizontal fusional amplitude

    Measured: Immediately following gameplay

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2015 (estimated)
  2. Study startDec 2014
  3. Primary completionMay 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02407015
Sponsor's protocol ID
URMS 138673
Status last verified
Oct 2015
First submitted
30 Mar 2015
Last updated
14 Oct 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Nintendo 3DS gameplay in people with Visual Fatigue, run by University of Sheffield at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in horizontal fusional amplitude (time frame: Immediately following gameplay). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in